Home Capital Broker's Calls

Potential listing of Acumen on Nasdaq may boost Q&M and Aoxin Q&M: UOBKH

Samantha Chiew
Samantha Chiew1/24/2022 12:48 PM GMT+08  • 3 min read
Potential listing of Acumen on Nasdaq may boost Q&M and Aoxin Q&M: UOBKH
Acumen's potential listing on Nasdaq bodes well for both Aoxin Q&M and Q&M Dental.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Acumen Diagnostics, a medical technology company that operates two laboratories in Singapore to provide swabbing and Covid-19 polymerase chain reaction (PCR) tests services is intending to list on the Nasdaq stock exchange in New York. Furthermore, Acumen has appointed an advisors to assist with the listing evaluation and all relevant preparatory work including the selection of professional advisors and underwriting banks.

Acumen is 50% owned by Q&M Dental Group and 49% owned by Q&M’s Chinese dental business Aoxin Q&M. If this listing goes through, Acumen would be Q&M’s second spin-off, with Aoxin Q&M being its first spin-off listing on the Catalist Board of Singapore Exchange (SGX) back in 2017.

The reasons for choosing Nasdaq is because it is one of the most well-known listing platforms in the world. Nasdaq is known for its technology, innovation, and it is home to digital, biotechnology, and other cutting edge companies.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now